A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

NCT02569372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: GC1102

Sponsor

Green Cross Corporation